Leads for antitubercular compounds from kinase inhibitor library screens - Wikidata - awgldk - TriplyDB

Leads for antitubercular compounds from kinase inhibitor library screens

Leads for antitubercular compounds from kinase inhibitor library screens

http://www.wikidata.org/entity/Q28487226

about

The application of tetracyclineregulated gene expression systems in the validation of novel drug targets in Mycobacterium tuberculosis Tuberculosis drug discovery in the post-post-genomic era Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis.New target prediction and visualization tools incorporating open source molecular fingerprints for TB Mobile 2.0 Crowd sourcing a new paradigm for interactome driven drug target identification in Mycobacterium tuberculosis Enhancing hit identification in Mycobacterium tuberculosis drug discovery using validated dual-event Bayesian models Pros and cons of the tuberculosis drugome approach--an empirical analysis Efficient Synthesis and Anti-Tubercular Activity of a Series of Spirocycles: An Exercise in Open Science Interaction of ATP with a small heat shock protein from Mycobacterium leprae: effect on its structure and function TB Mobile: a mobile app for anti-tuberculosis molecules with known targets Fusing dual-event data sets for Mycobacterium tuberculosis machine learning models and their evaluation.The phosphatidyl-myo-inositol mannosyltransferase PimA is essential for Mycobacterium tuberculosis growth in vitro and in vivo The mycobacterial cell envelope-lipids Screening of antifungal azole drugs and agrochemicals with an adapted alamarBlue-based assay demonstrates antibacterial activity of croconazole against Mycobacterium ulcerans.The cell envelope glycoconjugates of Mycobacterium tuberculosis Bayesian models leveraging bioactivity and cytotoxicity information for drug discovery.Combining computational methods for hit to lead optimization in Mycobacterium tuberculosis drug discovery.Yeast three-hybrid screening for identifying anti-tuberculosis drug targets.Syntheses and Antituberculosis Activity of 1,3-Benzothiazinone Sulfoxide and Sulfone Derived from BTZ043.Genetic Approaches to Facilitate Antibacterial Drug Development.Kinase Inhibitors that Increase the Sensitivity of Methicillin Resistant Staphylococcus aureus to β-Lactam Antibiotics.Identification of widespread adenosine nucleotide binding in Mycobacterium tuberculosis A chemical proteomics approach to profiling the ATP-binding proteome of Mycobacterium tuberculosis.Progress in targeting cell envelope biogenesis in Mycobacterium tuberculosis.Tuberculosis drugs: new candidates and how to find more.Challenges and opportunities in developing novel drugs for TB.Cytoskeletal proteins of actinobacteria.Antituberculars which target decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1: state of art.Social networks to biological networks: systems biology of Mycobacterium tuberculosis.The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis.MmpL3 a potential new target for development of novel anti-tuberculosis drugs.Trends in discovery of new drugs for tuberculosis therapy.The anti-tuberculosis agents under development and the challenges ahead.Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis.Inhibiting Mycobacterium tuberculosis within and without.Insight into the structural requirements of aminopyrimidine derivatives for good potency against both purified enzyme and whole cells of M. tuberculosis: combination of HQSAR, CoMSIA, and MD simulation studies.Assessing the essentiality of the decaprenyl-phospho-d-arabinofuranose pathway in Mycobacterium tuberculosis using conditional mutants.Key Structures and Interactions for Binding of Mycobacterium tuberculosis Protein Kinase B Inhibitors from Molecular Dynamics Simulation.Carboxylate Surrogates Enhance the Antimycobacterial Activity of UDP-Galactopyranose Mutase Probes.

P2860

Q26795478-C6283AFE-8DE0-498F-88FB-67391A5C3A67 Q26864729-081A5454-3EBE-481E-99BF-D8088BE860C4 Q27672587-986D9560-6F02-440E-BD9C-D3BD67FBEB6E Q27728459-BD910738-B516-4BC5-8EC1-CD9D2A1F5199 Q27902272-1B8BA1C5-E793-478F-A158-F0D41F87A771 Q28481300-77EC3B2B-8654-4AEA-85D4-E0F643D0E5BC Q28487748-453F5017-6924-477E-9048-BE9766AC297B Q28540138-D4D3B5CA-D181-4C2C-BC77-B5FEADA6392C Q28542633-9AB677BA-EEF3-4754-969B-5DB899706F06 Q28545057-AE27E04C-F099-43C2-8185-B0D92E63587B Q28709353-D91EAC33-AFAC-49DC-B41F-560509285E8F Q30681280-B88EE098-BCFA-4EBC-84DA-EDE7DE7447E5 Q34297745-D18E6B59-E88A-4456-AAA7-1D10F876D476 Q34355375-15A52740-B6DA-419C-81B9-5AE66A7267CD Q34420330-0FED604D-736E-4A8A-8051-69209F22F517 Q34423962-984A2BF6-1A97-46C9-96DD-1097A0CB2B8B Q34632430-CFD6CD8E-6288-42CF-B0C2-EDBB11C7C313 Q35019457-7711B758-9E58-4B99-8E01-06BF377D6C43 Q35019498-871DA50E-6EEA-4044-8E53-7EE0E73D7814 Q35086722-B3964172-7F25-44DF-8C88-B61A8CC927BF Q35795582-CF145373-D93A-4D5A-BE86-97B5FCD5E2CB Q35823106-C7BCCB45-D976-46AF-9268-CF7C4D3F056C Q36573627-B4DE572F-EEBE-4C26-AB17-347E9177862A Q36910805-3EC644FB-1940-44BD-8948-14BF1054C980 Q37403156-986C4E44-E42A-43B6-AF86-D107ED3B36D1 Q37894691-99E7B674-BD85-45D6-A545-8262DC2BBF05 Q37924294-66EA31E0-DD6F-4B1E-A368-E23F40FDBF01 Q38000559-85C29520-2558-4031-A0B4-D0A1A2099660 Q38004830-FD764494-E219-4EDA-9B6E-3A453D90E1A0 Q38102918-7CA5A38D-5E67-418D-869D-7BA62DD294DE Q38137731-F3DFB400-E22C-410F-82B4-B905AEC1E015 Q38170188-BD46CA8D-4398-4A22-BCD3-60177EAB59FB Q38237221-CE29C4FC-4717-4F1E-A1F3-C392DE97F416 Q38617197-23B9363B-610A-437D-9DEA-185E13A47CBE Q38751736-094A59B7-B2D0-4AF0-9AE2-2758B2415B4A Q38965421-C3EF3FCC-019A-41A7-BDA1-B4CB6136AFA6 Q38986810-0AA4790C-1697-4CFD-8D2C-F707557F844C Q39024963-3B6EAF8F-60D1-42FF-9E6A-ABEBDEA2505D Q39106409-950F6795-F3F0-42D6-BFF7-3611D0BF64C1 Q39392401-90498DA2-307F-49B6-86CA-23A9BC3A040A

P2860

Leads for antitubercular compounds from kinase inhibitor library screens

http://www.wikidata.org/entity/Q28487226

description

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2010

@ast

scientific journal article

@en

vedecký článok (publikovaný 2010/11/01)

@sk

vědecký článek publikovaný v roce 2010

@cs

wetenschappelijk artikel (gepubliceerd op 2010/11/01)

@nl

наукова стаття, опублікована в листопаді 2010

@uk

مقالة علمية (نشرت في نوفمبر 2010)

@ar

name

Leads for antitubercular compounds from kinase inhibitor library screens

@ast

Leads for antitubercular compounds from kinase inhibitor library screens

@en

Leads for antitubercular compounds from kinase inhibitor library screens

@nl

type

label

Leads for antitubercular compounds from kinase inhibitor library screens

@ast

Leads for antitubercular compounds from kinase inhibitor library screens

@en

Leads for antitubercular compounds from kinase inhibitor library screens

@nl

prefLabel

Leads for antitubercular compounds from kinase inhibitor library screens

@ast

Leads for antitubercular compounds from kinase inhibitor library screens

@en

Leads for antitubercular compounds from kinase inhibitor library screens

@nl

P1433

Q28487226-562D8A9F-DC9C-4A41-B9CA-3F1152722036

P1476

Q28487226-89DBB398-596D-4341-8A31-45B7F8952A80

P2093

Q28487226-09120D57-098D-4ADA-AF46-CC52D72AA5B6

Q28487226-2C841724-BA28-4089-A3A6-61EE5E402E2D

Q28487226-4E47ED0D-A311-48F5-95B4-AD885C106325

Q28487226-60CD3259-6669-4094-8F68-AE54A1FEB9FA

Q28487226-6FA6D606-5CA3-4ECC-BD59-4CFA57180FC0

Q28487226-83377836-A1D9-443E-BE3A-24929AD30460

Q28487226-8ECCFF19-ABBD-460F-B8E7-B2A8B8B8377A

Q28487226-9A64CA7B-116B-4FF9-806F-2A891527599B

Q28487226-B7C47C23-C396-4D20-897F-9CEE773D7442

Q28487226-D670471A-9CC1-45B8-9AD0-80CB438C0A2D

P304

Q28487226-076E31B7-21D8-47FA-AFF7-2937D555C37C

P31

Q28487226-4006CAE9-F8F7-46BE-9DC8-0E6844092FBC

P356

Q28487226-9DCDDC9E-AC1D-4774-817C-0FA4274F5E93

P433

Q28487226-AF0B21A8-EAE0-43AA-955F-FC0B39462C1E

P478

Q28487226-B1CBF6AE-EABD-4BEE-89EA-B698E3EB07D1

P50

Q28487226-84D018A9-EB03-425F-BBFD-1C81D7609F17

Q28487226-AD4A6D53-14A6-46B3-8B6C-7CFDB4992DC5

Q28487226-BB3FCDDA-3ED6-4363-9AED-F156BD03DA17

P577

Q28487226-96C89FD3-B493-4E58-B4A7-4A637E145B73

P5875

Q28487226-D181936A-476F-4D67-9D9E-099591EA2F1D

P698

Q28487226-43D65C61-3C36-4C66-B693-95F451975103

P356

J.TUBE.2010.09.001

P1433

P1476

Leads for antitubercular compounds from kinase inhibitor library screens

@en

P2093

Csaba Szántai-Kis

http://www.w3.org/2001/XMLSchema#string

Damiano Banfi

http://www.w3.org/2001/XMLSchema#string

György Kéri

http://www.w3.org/2001/XMLSchema#string

James A Triccas

http://www.w3.org/2001/XMLSchema#string

János Pató

http://www.w3.org/2001/XMLSchema#string

Manuel Bueno

http://www.w3.org/2001/XMLSchema#string

Marc Chambon

http://www.w3.org/2001/XMLSchema#string

Patricia Schneider

http://www.w3.org/2001/XMLSchema#string

Rita Székely

http://www.w3.org/2001/XMLSchema#string

Sophie Magnet

http://www.w3.org/2001/XMLSchema#string

P304

354-360

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TUBE.2010.09.001

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P50

Ruben Hartkoorn

Gerardo Turcatti

P577

2010-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47383581

http://www.w3.org/2001/XMLSchema#string

P698

20934382

http://www.w3.org/2001/XMLSchema#string